Surgical drains are implants that allow removal of fluid
and/or gas from a wound or body cavity. Surgical drains are tubes placed near
surgical incisions in the post-operative patient, to remove pus, blood or other
fluid, preventing it from accumulating in the body. They are active drains that
maintain a negative pressure gradient. Drains can help the healing process by
removing inflammatory mediators, bacteria, foreign material, and necrotic
tissue. Drains can relieve pressure that can impair perfusion or cause pain,
thereby decreasing morbidity and reducing inflammation, they enable monitoring
for potential complications by allowing easy sampling of fluid during healing;
and they can be used to address complications associated with dead space after
a pathology report has determined that neoplasia resection is complete and
margins are adequate.
Request for Sample
Report@ https://www.alliedmarketresearch.com/request-sample/7882
Key Market Players
- Braun Melsungen Ag
- Becton Dickinson & Company (C.R.Bard,
Inc.)
- Cardinal Health Inc.
- Convatec Group Plc
- Johnson & Johnson (Ethicon Inc.)
- Medline Industries Inc.
- Medtronic Plc.
- Redax S.P.A
- Romsons Group Private. Ltd
- Stryker Corporation
Growth of the
surgical drains market size is majorly driven by rise in chronic diseases and
increase in incidences and prevalence of chronic diseases (such as cancers and
cardiovascular diseases including heart diseases, strokes, and type II
diabetes) which have resulted in rise of cardiovascular surgeries and
cancer-related surgeries, for instance, cardiovascular disease is one of the
leading causes of deaths across the globe. According to the World Health
Organization, cardiovascular diseases (CVDs) are the leading cause of death
globally. An estimated 17.9 million people died from CVDs in 2019, representing
32% of all global deaths. Of these deaths, 85% were due to heart attack and
stroke. Out of the 17 million premature deaths (under the age of 70) due to
noncommunicable diseases in 2019, 38% were caused by CVDs which are the key
factors that propel growth of the surgical drains market.
Key Market
Segments
- By Product
- Open surgical drainage system
- Closed surgical drainage system
- By Application
- General Surgery
- Cardiac & Thoracic Surgery
- Orthopedic Surgery
- Obstetric/Gynecological Surgery
- Other Surgeries
- By Type
- Active Drains
- Passive Drains
- By End User
- Hospitals
- Ambulatory surgery centers (ASCs) &
clinics
- By
Region
- North
America
- Europe
- Asia-Pacific
- LAMEA
North America was the largest
shareholder in the surgical drains market forecast in 2020, owing to its
well-established healthcare infrastructure, and supportive government
regulations for product type commercialization are the major factors driving
the growth of the surgical drains market. However, Asia-Pacific is anticipated
to register the highest CAGR of 5.1%. Furthermore, by volume Asia-Pacific is
anticipated to register the highest CAGR of 3.7% during the forecast period,
due to the increasing penetration of healthcare companies that are investing
heavily in the region. Changing healthcare reforms are contributing to the
growth of the market by allowing the commercialization of new products.
0 Comments